🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an immunogenicity and safety study of Gardasil (V501) in females 9 ...
Status
Completed
Location
Multiple Locations
Start Date
2005-10
Trial ID
NCT00157950
The study is designed to determine the safety, tolerability and immunogenic...
Status
Completed
Location
Multiple Locations
Start Date
2011-03-21
Trial ID
NCT01245764
This study evaluated the long-term safety of quadrivalent Human Papillomavi...
Status
Completed
Location
Multiple Locations
Start Date
2011-11-25
Trial ID
NCT01544478
Treatments Being Tested
Infection with human papillomavirus (HPV) has been clearly established as t...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-10-26
Trial ID
NCT01031069
Data from this study are expected to demonstrate that V501 (Human Papilloma...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00325130
This study was conducted to demonstrate that Gardasil™ (quadrivalent human ...
Status
Completed
Location
Multiple Locations
Start Date
2004-09-03
Trial ID
NCT00090285
This study is to evaluate the safety, tolerability, and immune response of ...
Status
Completed
Location
Multiple Locations
Start Date
2003-10-08
Trial ID
NCT00092547
Treatments Being Tested
A study to test the safety and effectiveness of Quadrivalent HPV (types 6, ...
Status
Completed
Location
Multiple Locations
Start Date
2008-12-31
Trial ID
NCT00834106
This study will examine the safety and tolerability of octavalent Human Pap...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00851643
This study will collect safety information on the use of GARDASIL™ in the P...
Status
Terminated
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT01355003